<DOC>
	<DOCNO>NCT00230672</DOCNO>
	<brief_summary>Hereditary Haemorrhagic Telangiectasia ( HHT , also know Osler-Weber-Rendu Syndrome ) disease lead development dilate fragile blood vessel , include arteriovenous malformation lung ( PAVMs ) . We hypothesize genetically-determined abnormality blood vessel HHT patient lead alteration concentration activity several protein blood stream . We propose take blood sample patient define time order study change blood protein level activity</brief_summary>
	<brief_title>Investigation Plasma Proteins Patients With Hereditary Haemorrhagic Telangiectasia PAVMs</brief_title>
	<detailed_description />
	<mesh_term>Telangiectasis</mesh_term>
	<mesh_term>Arteriovenous Malformations</mesh_term>
	<mesh_term>Telangiectasia , Hereditary Hemorrhagic</mesh_term>
	<criteria>Patients hereditary haemorrhagic telangiectasia pulmonary arteriovenous malformation Unable provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
</DOC>